Article metrics

Download PDFPDF
Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer

 

Online download statistics by month:

Online download statistics by month: January 2022 to October 2024

AbstractFullPdf
Jan 20224751510
Feb 2022457169
Mar 2022329129
Apr 202210844118
May 20223721613
Jun 2022430219
Jul 202220475
Aug 202223844
Sep 202223886
Oct 202224330
Nov 202220463
Dec 202214963
Jan 202330056
Feb 202330820
Mar 202315840
Apr 202316643
May 202313031
Jun 202312744
Jul 20239612
Aug 202314030
Sep 202313095
Oct 202316731
Nov 202316364
Dec 202320141
Jan 202419381
Feb 202413123
Mar 202414331
Apr 202418631
May 202417021
Jun 202412734
Jul 202415425
Aug 20248530
Sep 202414280
Oct 202411242
Total7952241134